Evidence map›Paper›PMID 36353688›Full record

ArticleFrontiers in aging neuroscience2022

TREM2 improves neurological dysfunction and attenuates neuroinflammation, TLR signaling and neuronal apoptosis in the acute phase of intracerebral hemorrhage.

Sidan Liu, Xuezhao Cao, Zhe Wu, Shumin Deng, Hefei Fu, Yanzhe Wang, Fang Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Multi-omics reveals the protective mechanisms ofFrontiers in pharmacology · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Microglia, Trem2, and Neurodegeneration.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  16. Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  17. TREM2Frontiers in immunology · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sidan LiuDepartment of Anesthesiology, the First Hospital of China Medical University, Shenyang, China.
Xuezhao CaoDepartment of Anesthesiology, the First Hospital of China Medical University, Shenyang, China.
Zhe WuDepartment of Neurology, the First Hospital of China Medical University, Shenyang, China.
Shumin DengDepartment of Neurology, the First Hospital of China Medical University, Shenyang, China.
Hefei FuDepartment of Neurology, the First Hospital of China Medical University, Shenyang, China.
Yanzhe WangDepartment of Neurology, the First Hospital of China Medical University, Shenyang, China.
Fang LiuDepartment of Neurology, the First Hospital of China Medical University, Shenyang, China.
First Hospital of China Medical University · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroinflammation contributes to secondary brain injury following intracerebral hemorrhage (ICH). Triggering receptor expressed on myeloid cells 2 (TREM2) confers strong neuroprotective effect by suppressing neuroinflammatory response in experimental ischemic stroke. This study aimed to clarify the neuroprotective role of TREM2 and potential underlying mechanism in a mouse model of ICH and

Indexed as

intracerebral hemorrhagemicroglianeuroinflammationTAK242TLR4TREM2

Identifiers

PMID36353688
PMCPMC9637852
OpenAlexW4307274075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.